Primary Site >> Stomach Cancer
Gene >> IGF2BP3
| 1. | |||||||||||
| Journal: | Clin Cancer Res. 2003 Nov 1;9(14):5120-6. | ||||||||||
| Title: | Recursive partitioning as an approach to selection of immune markers for tumor diagnosis. | ||||||||||
| Author: | Koziol, James A|Zhang, Jian-Ying|Casiano, Carlos A|Peng, Xuan-Xian|Shi, Fu-Dong|Feng, Anne C|Chan, Edward K L|Tan, Eng M | ||||||||||
| PMID: | 14613989 | ||||||||||
| 2. | |||||||||||
| Journal: | Anticancer Res. 2017 Jan;37(1):135-142. | ||||||||||
| Title: | Clinicopathological Implication of Insulin-like Growth Factor-II mRNA-Binding Protein 3 (IMP3) Expression in Gastric Cancer. | ||||||||||
| Author: | Lee, Dakeun|Yu, Eun Ji|Ham, In-Hye|Hur, Hoon | ||||||||||
| PMID: | 28011483 | ||||||||||
| 3. | |||||||||||
| Journal: | Mol Cancer. 2017 Apr 11;16(1):77. | ||||||||||
| Title: | IGF2BP3 functions as a potential oncogene and is a crucial target of miR-34a in gastric carcinogenesis. | ||||||||||
| Author: | Zhou, Yuhang|Huang, Tingting|Siu, Ho Lam|Wong, Chi Chun|Dong, Yujuan|Wu, Feng|Zhang, Bin|Wu, William K K|Cheng, Alfred S L|Yu, Jun|To, Ka Fai|Kang, Wei | ||||||||||
| PMID: | 28399871 | ||||||||||
| 4. | |||||||||||
| Journal: | Onco Targets Ther. 2017 Jun 6;10:2849-2863. | ||||||||||
| Title: | Prognostic value of high IMP3 expression in solid tumors: a meta-analysis. | ||||||||||
| Author: | Chen, Luyao|Xie, Yongpeng|Li, Xintao|Gu, Liangyou|Gao, Yu|Tang, Lu|Chen, Jianwen|Zhang, Xu | ||||||||||
| PMID: | 28652767 | ||||||||||
| 5. | |||||||||||
| Journal: | Oncotarget. 2017 Aug 5;8(43):74567-74581. | ||||||||||
| Title: | The H19-PEG10/IGF2BP3 axis promotes gastric cancer progression in patients with high lymph node ratios. | ||||||||||
| Author: | Ishii, Satoru|Yamashita, Keishi|Harada, Hiroki|Ushiku, Hideki|Tanaka, Toshimichi|Nishizawa, Nobuyuki|Yokoi, Keigo|Washio, Marie|Ema, Akira|Mieno, Hiroaki|Moriya, Hiromitsu|Hosoda, Kei|Waraya, Mina|Katoh, Hiroshi|Watanabe, Masahiko | ||||||||||
| PMID: | 29088808 | ||||||||||